Comparison of efficacy of bromfenac sodium 0.1% ophthalmic solution and fluorometholone 0.02% ophthalmic suspension for the treatment of allergic conjunctivitis

Journal of Ocular Pharmacology and Therapeutics

Volumn 25, Issue 3, 2009, Pages 265-269

  Fujishima, Hiroshi ^a   Fukagawa, Kazumi ^a,b   Takano, Yoji ^a   Tanaka, Mari ^a,c   Okamoto, Shigeki ^d   Miyazaki, Dai ^e   Yamada, Jun ^f   Fukushima, Atsuki ^g   Uchio, Eiichi ^h   Nakagawa, Yayoi ⁱ  

^a International University of Health and Welfare Mita Hospital   (Japan)

^b Ryogoku Eye Clinic   (Japan)

^c Yatsuekimae Ajisai Eye Clinic   (Japan)

^d Okamoto Eye Clinic   (Japan)

^e TOTTORI UNIVERSITY   (Japan)

^f MEIJI UNIVERSITY OF INTEGRATIVE MEDICINE   (Japan)

^g KOCHI MEDICAL SCHOOL   (Japan)

^h FUKUOKA UNIVERSITY   (Japan)

ⁱ Nakagawa Eye Clinic   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BROMFENAC; CROMOGLYCATE DISODIUM; FLUOROMETHOLONE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORNEA DISEASE; CORNEAL EPITHELITIS; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; HUMAN; INTRAOCULAR PRESSURE ABNORMALITY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; SEASONAL ALLERGIC CONJUNCTIVITIS; SINGLE BLIND PROCEDURE; SUSPENSION; VISUAL ANALOG SCALE;

ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; AGED; ANTI-ALLERGIC AGENTS; ANTI-ASTHMATIC AGENTS; BENZOPHENONES; BROMOBENZENES; CONJUNCTIVITIS, ALLERGIC; CROMOLYN SODIUM; DRUG THERAPY, COMBINATION; FEMALE; FLUOROMETHOLONE; HUMANS; MALE; MIDDLE AGED; OPHTHALMIC SOLUTIONS; PATIENT SATISFACTION; SUSPENSIONS;

EID: 66249101621     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.2008.0121     Document Type: Article

References (15)

1. Proud, D., Sweet, J., Stein, P., et al. Inf ammatory mediator release on conjunctival provocation of allergic subjects with allergen. J. Allergy Clin. Immunol. 85:896-905, 1990.
2. Cook, E.B., Stahl, J.L., Barney, N.P., et al. Olopatadine inhibits TNFalpha release from human conjunctival mast cells. Ann. Allergy Asthma Immunol. 84:504-508, 2000.
3. Vesaluoma, M., Rosenberg, M.E., Teppo, A., et al. Tumour necrosis factor alpha (TNFalpha) in tears of atopic patients after conjunctival allergen challenge. Clin. Exp. Allergy. 29:537-542, 1999.
4. Fukagawa, K., Tsubota, K., Simmura, S., et al. Chemokine production in conjunctival epithelial cells. Adv. Exp. Med. Biol. 438:471-478, 1998.
5. Ennis, M., Barrow, S.E., Blair, I.A. Prostaglandin and histamine release from stimulated rat peritoneal mast cells. Agents Actions 14:397-400, 1984.
6. Tinkelman, D.G., Rupp, G., Kaufman, H., et al. Double-masked, paired-comparison clinical study of ketorolac tromethamine 0.5% ophthalmic solution compared with placebo eyedrops in the treatment of seasonal allergic conjunctivitis. Surv. Ophthalmol. 38(Suppl):133-140, 1993.
7. Tauber, J., Raizman, M.B., Ostrov, C.S., et al. A multicenter comparison of the ocular eff cacy and safety of diclofenac 0.1% solution with that of ketorolac 0.5% solution in patients with acute seasonal allergic conjunctivitis. J. Ocul. Pharmacol. Ther. 14:137-14 5, 19 9 8.
8. Walsh, D.A., Moran, H.W., Shamblee, D.A., et al. Antiinf ammatory agents. 3. Synthesis and pharmacological evaluation of 2-amino-3-benzoylphenylacetic acid and analogues. J. Med. Chem. 27:1379-1388, 1984.
9. Kida, T., Ogawa, T., McNamara, T.R., et al. Evaluations of the human COX-1 and COX-2 inhibition for amfenac, bromfenac, diclofenac, and ketorolac. Poster presented at the annual meeting of the American College of Clinical Pharmacy (ACCP), October 14-17, 2007, Denver, CO.
10. Uchio, E., Kimura, R., Migita, H., et al. Demographic aspects of allergic ocular diseases and evaluation of new criteria for clinical assessment of ocular allergy. Graefes Arch. Clin. Exp. Ophthalmol. 246:291-296, 2008.
11. Miyake-Kashima, M., Takano, Y., Tanaka, M., et al. Comparison of 0.1% bromfenac sodium and 0.1% pemirolast potassium for the treatment of allergic conjunctivitis. Jpn J. Ophthalmol. 48:587-590, 2004.
12. Butrus, S., Portela, R. Ocular allergy: diagnosis and treatment. Ophthalmol. Clin. North Am. 18:485-492, 2005.
13. Yaylali, V., Demirlenk, I., Tatlipinar, S., et al. Comparative study of 0.1% olopatadine hydrochloride and 0.5% ketorolac tromethamine in the treatment of seasonal allergic conjunctivitis. Acta. Ophthalmol. Scand. 81:378-382, 2003.
14. Woodward, D.F., Nieves, A.L., Friedlaender, M.H. Characterization of receptor subtypes involved in prostanoid-induced conjunctival pruritus and their role in mediating allergic conjunctival itching. J. Pharmacol. Exp. Ther. 279:137-142, 1996.
15. Hashimoto, T., Igarashi, A., Hoshina, F., et al. Effects of nonsteroi dal anti-inf ammatory drugs on experimental allergic conjunctivitis in guinea pigs. J. Ocul. Pharmacol. Ther. 19:569-577, 2003.